---
id: smfm-preterm-labor-2024
title: "SMFM 2024 Consult Series: Preterm Labor Management"
short_title: "SMFM Preterm Labor 2024"

organization: Society for Maternal-Fetal Medicine
collaborators: null
country: US
url: https://www.smfm.org/publications
doi: null
pmid: null
open_access: true

specialty: obstetrics-gynecology
guideline_type: clinical-practice
evidence_system: SMFM
conditions:
  - preterm labor
  - preterm birth
  - tocolysis
tags:
  - tocolytics
  - antenatal corticosteroids
  - magnesium sulfate
  - progesterone
  - cervical length

publication_date: 2024-06-01
previous_version_date: 2022-01-01
status: current
supersedes: null
superseded_by: null

pdf_path: null
has_pdf: false
last_reviewed: 2025-12-26
---

## Scope
2024 SMFM consult series on the evaluation and management of preterm labor and strategies to prevent preterm birth.

## Key Recommendations

### Definition
- Preterm labor: Regular uterine contractions with cervical change before 37 weeks.
- Threatens preterm birth, a leading cause of neonatal morbidity/mortality.

### Evaluation
- Confirm gestational age.
- Cervical length (TVUS): <25 mm at <24 weeks is short cervix.
- Fetal fibronectin (fFN): Negative test has high NPV.

### Acute Management of Preterm Labor

#### Tocolytics
- **Goal**: Delay delivery 48 hours to complete corticosteroids.
- **Nifedipine (Calcium Channel Blocker)**: First-line.
- **Indomethacin (NSAID)**: Effective, especially <32 weeks (avoid prolonged use â€“ oligohydramnios, ductus closure).
- **Magnesium Sulfate**: Alternative; also provides neuroprotection <32 weeks.
- **Beta-Agonists (Terbutaline)**: Limited use due to side effects.
- Tocolysis is not indicated after 34 weeks; benefits diminish.

#### Antenatal Corticosteroids
- **Betamethasone or Dexamethasone**: Administer to women at risk of delivery within 7 days, between 24+0 and 33+6 weeks.
- Single rescue course may be considered if prior course >14 days ago and high risk.
- May be considered from 34+0 to 36+6 weeks if not previously received.

#### Magnesium Sulfate for Neuroprotection
- Administer if delivery expected <32 weeks to reduce risk of cerebral palsy.

### Prevention (Recurrent Preterm Birth or Short Cervix)
- **Vaginal Progesterone**: For short cervix (<25 mm) in singleton pregnancy.
- **Cerclage**: For history of prior preterm birth + short cervix.
- **17-OHPC (17-alpha hydroxyprogesterone caproate)**: Previous recommendations; recent data show limited benefit. Individualized use.

### Antibiotics
- Treat GBS-positive patients per guidelines.
- Treat concomitant infections (e.g., UTI, BV if symptomatic).
